Search Results

Search Results for "diabetes"

• Expert wants more study into Byetta, Januvia pancreatitis risk
  The author of a study that found two diabetes drugs may double the risk of a dangerous pancreas inflammation says his findings show a need for more research into the subject. Bloomberg has reported on the study, which found that Merck’s diabetes drug Januvia and Bristol-Myers Squibb’s Byetta may...

• Consumers cautioned against Januvia and Byetta
  A blog entry on Consumer Reports recommends that patients taking the diabetes medications Byetta or Januvia ask their doctors about possibly taking other medications. According to Consumer Reports, people taking those two drugs may have a small but increased risk for a condition marked by stomach pa...

• Analysis finds Byetta, Januvia linked to pancreatitis
  A new analysis of insurance records published in the journal JAMA Internal Medicine adds to growing evidence of a connection between two popular diabetes drugs and a potentially deadly inflammation of the pancreas. According to a report on the study in Bloomberg, patients hospitalized with pancreati...

• FDA investigates blood pressure medication
  The U.S. Food and Drug Administration launched an investigation into whether the blood pressure medication Benicar increases the risk of heart-related deaths, Reuters reports. According to the story, the agency is evaluating clinical data from two drug trials. In both of them, diabetes patients who ...

• Byetta may help with weight loss, but has side effects
  A recent study shows that the type 2 diabetes drug Byetta may help severely overweight teens lose weight. But a story in U.S. News and Word Report notes that the weight losses were modest and subjects experienced side effects including nausea and vomiting. The drug is also expensive, at $350 or more...

• Merck delays approval for new drug
  According to a story in the New York Times, Merck is delaying its attempts to get approval for an experimental osteoporosis drug called odanacatib, because it is seeking additional data from a clinical trial. That announcement helped send the company’s shares down 3 percent. The story says Merck r...

• Stem cells appear to aid stroke recovery
  Researchers in Bolivia have announced that rats injected with stem cells recovered from strokes more quickly, and their findings have potential for treating human stroke victims. According to a BBC story, current best practice for stroke treatment is to treat many patients with “clot-busting&#...

• Medical conditions can trigger stroke
  While it’s impossible to predict exactly who will suffer a stroke, medical experts have identified a number of risk factors. Among them are use of alcohol or tobacco, long periods of physical inactivity, pregnancy and use of birth control pills. Although all birth control pills can increase the ri...

• Merck recalling heart medication
  Pharmaceutical giant Merck is withdrawing its heart drug Tredaptive from the market in 40 countries after a study showed that it didn’t work, and caused more serious side effects than placebos. A report on NPR says the drug was meant to prevent heart disease and stroke by promoting good cholestero...

• FDA Claims Manufacturer Withheld Info
  According to U.S. Food and Drug Administration documents, the manufacturer of diabetes drug Byetta tried to conceal from federal regulators a study that linked the drug to potential heart problems. In large part because of Amylin Pharmaceuticals’ deceitfulness, The Street reports, the FDA rejected...